Long-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial: Erratum
- PMID: 30593216
- PMCID: PMC6314773
- DOI: 10.1097/MD.0000000000013948
Long-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial: Erratum
Erratum for
-
Long-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial.Medicine (Baltimore). 2018 Nov;97(45):e13120. doi: 10.1097/MD.0000000000013120. Medicine (Baltimore). 2018. PMID: 30407329 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
